Systems pharmacology-based drug discovery from Amaryllidaceae alkaloids and investigation of mechanisms of action in treatment of Alzheimer’s disease
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgae113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Jianing Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: SKL of Marine Food Processing & Safety Control, National Engineering Research Center of Seafood, School of Food Science and Technology, Dalian Polyte…. Hauptthemen laut MEDLINE: Alzheimer Disease, Drug Discovery, Amaryllidaceae Alkaloids, Amaryllidaceae. Die Arbeit nennt 87 Literaturangaben. Gefördert von: Natural Science Foundation of Liaoning Province, National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
Objectives
Given the success of galanthamine in treating Alzheimer’s disease, this study aims to establish an effective method to find drugs from Amaryllidaceae alkaloids and to clarify its mechanism in treating Alzheimer’s disease.
Methods
The pharmacodynamic basis and mechanism of action between Amaryllidaceae alkaloids and Alzheimer’s disease were explored by constructing a compound-target-disease network, targets protein-protein interaction, gene ontology, Kyoto Encyclopedia of Genes and Genomes pathway enrichment, and molecular docking verification. Key findings In total, a chemical library of 357 potential alkaloids was constructed. A total of 100 active alkaloid components were identified. Thirty-nine associated targets were yielded based on network construction, and the key targets were defined as HSP90AA1, ESR1, NOS3, PTGS2, and PPARG using protein–protein interaction network. Gene ontology items (490) and 68 Kyoto Encyclopedia of Genes and Genomes pathways were selected through the enrichment of target functions, including neuroactive ligand–receptor interaction, calcium signaling pathway, cAMP signaling pathway, Alzheimer disease, and serotonergic synapse that were related to Alzheimer’s disease. Lastly, molecular docking demonstrated good stability in combining selected alkaloids with targets.
Conclusions
This study explained the mechanisms of Amaryllidaceae alkaloids in preventing and treating Alzheimer’s disease and established a novel strategy to discover new drugs from biological chemical sources.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- SKL of Marine Food Processing & Safety Control, National Engineering Research Center of Seafood, School of Food Science and Technology, Dalian Polytechnic University, Dalian, Liaoning 116034, China.
- MabPlex International Co., Ltd., Yantai, Shandong 264006, China.
- Human Resources Department, Shenyang Jianzhu University, Shenyang, Liaoning 110168, China.
- College of Basic Medical Science, Dalian Medical University, Dalian, Liaoning 116044, China.
- Korean Medicine (KM) Application Center, Korea Institute of Oriental Medicine, Daegu 41062, Korea.
ORCID-Profile: Yan Ding
Förderung
- Natural Science Foundation of Liaoning Province
- National Natural Science Foundation of China
Zitieren
APA
Li, J., Chen, J., Qu, D., Zhu, L., Ye, S., Li, M., Li, W., & Ding, Y. (2025). Systems pharmacology-based drug discovery from Amaryllidaceae alkaloids and investigation of mechanisms of action in treatment of Alzheimer’s disease. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae113
Vancouver
Li J, Chen J, Qu D, Zhu L, Ye S, Li M, et al. Systems pharmacology-based drug discovery from Amaryllidaceae alkaloids and investigation of mechanisms of action in treatment of Alzheimer’s disease. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgae113
BibTeX
@article{Li2025,
author = {Li, Jianing and Chen, Jialiang and Qu, Dan and Zhu, Lin and Ye, Shuhong and Li, Ming and Li, Wei and Ding, Yan},
title = {Systems pharmacology-based drug discovery from Amaryllidaceae alkaloids and investigation of mechanisms of action in treatment of Alzheimer’s disease},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgae113}
}
EUVIMED